Kettering University

2018–2025 · program · P50

RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer

David B. Solit · Kettering University · funded by National Institutes of Health

2018–2024 · program · P50

Targeting Oncogenic Pathways in Genetically Complex Sarcomas

Samuel Singer · Kettering University · funded by National Institutes of Health

2017–2022 · research · R01

Ferroptosis, Cellular Metabolism, and Cancer

Xuejun Jiang · Kettering University · funded by National Institutes of Health

$396.3kFerroptosis and cancer prognosis

2017–2028 · research · R25

Quantitative Sciences Summer Undergraduate Research Experience (QSURE)

Colin B Begg · Kettering University · funded by National Institutes of Health

$174.6k

2017–2022 · research · R01

P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment

Daniel Alan Heller · Kettering University · funded by National Institutes of Health

$639.3k

2017–2022 · career development · K23

Enhancing Understanding of Harms and Benefits of Cardiac Monitoring During Breast Cancer Therapy

Anthony Francis Yu · Kettering University · funded by National Institutes of Health

$172.9kChemotherapy-induced cardiotoxicity and mitigation

2017–2025 · research · R01

Mechanisms of Lipid Droplet Formation

Robert V Farese · Kettering University · funded by National Institutes of Health

$332.7kLipid metabolism and biosynthesis

2017–2022 · research · R01

Imaging tumor and T cell responses to metabolic and immune modulation therapy

Ronald George Blasberg · Kettering University · funded by National Institutes of Health

$70.5kCancer Immunotherapy and Biomarkers

2017–2022 · research · R01

Exploiting ferroportin for cancer imaging and therapy

Jan Grimm · Kettering University · funded by National Institutes of Health

$502k

2017–2021 · research · R01

Lineages and pathophysiology of clonal histiocytic disorders

Frederic Geissmann · Kettering University · funded by National Institutes of Health

$714.1kHistiocytic Disorders and Treatments

2017–2020 · fellowship · F32

Mechanisms of epithelial remodeling in the mouse embryo

Marissa Lynn Gredler · Kettering University · funded by National Institutes of Health

$61.2k

2017–2022 · research · R25

Quantitative Sciences Summer Undergraduate Research Experience (QSURE) Fellowship

Colin B Begg · Kettering University · funded by National Institutes of Health

$117.6k

2017–2022 · research · R35

Investigating long noncoding RNAs as regulators of the p53 pathway functions.

Adam Schmitt · Kettering University · funded by National Institutes of Health

$428.5kCancer-related molecular mechanisms research

2017–2023 · cooperative agreement · UH3

Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries

Olusegun Isaac Alatise · Kettering University · funded by National Institutes of Health

$751.1kMetabolomics and Mass Spectrometry Studies

2017–2021 · research · R01

Inferential methods to assess the incremental value of new biomarkers in risk classification models

Glenn Heller · Kettering University · funded by National Institutes of Health

$285.1k

2017–2021 · cooperative agreement · U01

Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D

Christina S Leslie · Kettering University · funded by National Institutes of Health

$717.3kGenomics and Chromatin Dynamics

2017–2020 · research · R00

The origins of chromosome rearrangement in the cancer genome

John Maciejowski · Kettering University · funded by National Institutes of Health

$238k

2017–2021 · research · R01

Therapeutic approaches to ER mutant breast cancer

Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health

$392.1kEstrogen and related hormone effects

2017–2019 · research · R56

Natural killer cell and T-cell crosstalk in CMV infection

Katharine C Hsu · Kettering University · funded by National Institutes of Health

$306.3k

2017–2022 · research · R01

Exploiting ferroportin for cancer imaging and therapy

Jan Grimm · Kettering University · funded by National Institutes of Health

$604.8k

2017–2021 · cooperative agreement · U01

Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D

Christina S Leslie · Kettering University · funded by National Institutes of Health

$742.5kGenomics and Chromatin Dynamics

2017–2022 · research · R01

Protein and proteolytic activity biomarkers of early stage pancreatic cancer

Paul Tempst · Kettering University · funded by National Institutes of Health

$642.5k

2017–2022 · research · R01

Schwann Cell Reprogramming and Cancer Perineural Invasion

Richard J Wong · Kettering University · funded by National Institutes of Health

$597.3kCancer, Stress, Anesthesia, and Immune Response

2017–2022 · research · R01

BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma

David R Jones · Kettering University · funded by National Institutes of Health

$543.1kMechanisms of cancer metastasis

2017–2023 · research · R35

Synergistic role of signaling and epigenetics in leukemic transformation

Ross L Levine · Kettering University · funded by National Institutes of Health

$1.1MAcute Myeloid Leukemia Research

2017–2022 · research · R01

Ferroptosis, Cellular Metabolism, and Cancer

Xuejun Jiang · Kettering University · funded by National Institutes of Health

$415.2kFerroptosis and cancer prognosis

2017–2022 · research · R01

Schwann Cell Reprogramming and Cancer Perineural Invasion

Richard J Wong · Kettering University · funded by National Institutes of Health

$640.7kCancer, Stress, Anesthesia, and Immune Response

2017–2021 · research · R01

Therapeutic approaches to ER mutant breast cancer

Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health

$380.3kEstrogen and related hormone effects

2017–2022 · research · R01

Structure and function of genome plasticity in human cancer

Alex Kentsis · Kettering University · funded by National Institutes of Health

$482.1kChromatin Remodeling and Cancer

2017–2022 · cooperative agreement · U24

The cBioPortal for Cancer Genomics

Ethan Cerami · Kettering University · funded by National Institutes of Health

$1.3M

2017–2022 · research · R01

Understanding Long Tail Driver Mutations in Cancer

Barry Stephen Taylor · Kettering University · funded by National Institutes of Health

$392.1kCancer Genomics and Diagnostics

2017–2022 · research · R01

Understanding Long Tail Driver Mutations in Cancer

Nikolaus Schultz · Kettering University · funded by National Institutes of Health

$410.8kCancer Genomics and Diagnostics

2017–2022 · cooperative agreement · U01

Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI Syndrome

Richard N Kolesnick · Kettering University · funded by National Institutes of Health

$593.6kSphingolipid Metabolism and Signaling

2017–2018 · research · R01

A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma

Neeta Pandit Taskar · Kettering University · funded by National Institutes of Health

$392.1kNeuroblastoma Research and Treatments

2017–2020 · fellowship · Doctoral Award - Doctoral Foreign Study Award (DFSA)

Evaluation of novel cancer immunotherapies that combine the potency of chimeric antigen receptors and the intracellular targeting of T-cell receptors

Anton Dobrin · Kettering University · funded by Canadian Institutes of Health Research

CAD 115kCAR-T cell therapy research

2017–2022 · research · R01

Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance

Yu Chen · Kettering University · funded by National Institutes of Health

$498.6k

2017–2021 · research · R01

Phase2 trial of MEK162 & imatinib combined therapy in GIST, IND119794(09/20/2013)

Ping Chi · Kettering University · funded by U.S. Food and Drug Administration

$500k

2017–2023 · cooperative agreement · UH3

Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries

Olusegun Isaac Alatise · Kettering University · funded by National Institutes of Health

$767kMetabolomics and Mass Spectrometry Studies

2017–2022 · cooperative agreement · U01

Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI Syndrome

Richard N Kolesnick · Kettering University · funded by National Institutes of Health

$604.8kSphingolipid Metabolism and Signaling

2017–2022 · research · R01

Imaging tumor and T cell responses to metabolic and immune modulation therapy

Ronald George Blasberg · Kettering University · funded by National Institutes of Health

$718.8kCancer Immunotherapy and Biomarkers